Cavia porcellus as a model for experimental infection by Trypanosoma cruzi
- PMID: 21703410
- PMCID: PMC3123796
- DOI: 10.1016/j.ajpath.2011.03.043
Cavia porcellus as a model for experimental infection by Trypanosoma cruzi
Abstract
The guinea pig (Cavia porcellus) is a natural reservoir for Trypanosoma cruzi but has seldom been used as an experimental infection model. We developed a guinea pig infection model for acute and chronic Chagas disease. Seventy-two guinea pigs were inoculated intradermally with 10(4) trypomastigotes of T. cruzi strain Y (experimental group); 18 guinea pigs were used as control group. Eight animals from the experimental group and two from the control group were sacrificed 5, 15, 20, 25, 40, 55, 115, 165, and 365 days after inoculation. During the acute phase (15 to 55 days), we observed parasitemia (with a peak on day 20) and positive IgM and IgG Western blots with anti-shed acute-phase antigen bands. The cardiac tissue showed vasculitis, necrosis (on days 40 to 55), moderate to severe inflammation, and abundant amastigote nests. Smaller numbers of amastigote nests were also present in kidney, brain, and other organs. In the early chronic phase (115 to 165 days), parasitemia disappeared and anti-T. cruzi IgG antibodies were still detectable. In cardiac tissue, the number of amastigote nests and the grade of inflammation decreased. In the chronic phase (365 days), the cardiac tissue showed vasculitis and fibrosis; detectable parasite DNA was associated with higher grades of inflammation. The experimental T. cruzi infection model in guinea pigs shows kinetics and pathologic changes similar to those of the human disease.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Figures







Similar articles
-
Quantitative and histological assessment of maternal-fetal transmission of Trypanosoma cruzi in guinea pigs: An experimental model of congenital Chagas disease.PLoS Negl Trop Dis. 2018 Jan 24;12(1):e0006222. doi: 10.1371/journal.pntd.0006222. eCollection 2018 Jan. PLoS Negl Trop Dis. 2018. PMID: 29364882 Free PMC article.
-
Domestic Pig (Sus scrofa) as an Animal Model for Experimental Trypanosoma cruzi Infection.Am J Trop Med Hyg. 2016 May 4;94(5):1020-7. doi: 10.4269/ajtmh.15-0233. Epub 2016 Feb 29. Am J Trop Med Hyg. 2016. PMID: 26928841 Free PMC article.
-
Vaccination with Trypanosoma rangeli induces resistance of guinea pigs to virulent Trypanosoma cruzi.Vet Immunol Immunopathol. 2014 Jan 15;157(1-2):119-23. doi: 10.1016/j.vetimm.2013.10.011. Epub 2013 Oct 29. Vet Immunol Immunopathol. 2014. PMID: 24275040
-
Infection by the Sylvio X10/4 clone of Trypanosoma cruzi: relevance of a low-virulence model of Chagas' disease.Microbes Infect. 2009 Nov;11(13):1037-45. doi: 10.1016/j.micinf.2009.07.011. Epub 2009 Aug 4. Microbes Infect. 2009. PMID: 19660570 Review.
-
Nonsteroidal Anti-Inflammatory Drugs and Experimental Chagas Disease: An Unsolved Question.Parasite Immunol. 2024 Jul;46(7):e13057. doi: 10.1111/pim.13057. Parasite Immunol. 2024. PMID: 39008292 Review.
Cited by
-
Translational challenges of animal models in Chagas disease drug development: a review.Drug Des Devel Ther. 2015 Aug 19;9:4807-23. doi: 10.2147/DDDT.S90208. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26316715 Free PMC article. Review.
-
Quantitative and histological assessment of maternal-fetal transmission of Trypanosoma cruzi in guinea pigs: An experimental model of congenital Chagas disease.PLoS Negl Trop Dis. 2018 Jan 24;12(1):e0006222. doi: 10.1371/journal.pntd.0006222. eCollection 2018 Jan. PLoS Negl Trop Dis. 2018. PMID: 29364882 Free PMC article.
-
Bottlenecks in domestic animal populations can facilitate the emergence of Trypanosoma cruzi, the aetiological agent of Chagas disease.Proc Biol Sci. 2015 Jul 7;282(1810):20142807. doi: 10.1098/rspb.2014.2807. Proc Biol Sci. 2015. PMID: 26085582 Free PMC article.
-
Insights from the use of erythropoietin in experimental Chagas disease.Int J Parasitol Drugs Drug Resist. 2022 Aug;19:65-80. doi: 10.1016/j.ijpddr.2022.05.005. Epub 2022 Jun 17. Int J Parasitol Drugs Drug Resist. 2022. PMID: 35772309 Free PMC article.
-
Characterization of guinea pig antibody responses to salivary proteins of Triatoma infestans for the development of a triatomine exposure marker.PLoS Negl Trop Dis. 2014 Apr 3;8(4):e2783. doi: 10.1371/journal.pntd.0002783. eCollection 2014 Apr. PLoS Negl Trop Dis. 2014. PMID: 24699441 Free PMC article.
References
-
- Organización Panamericana de la Salud . Organización Panamericana de la Salud; Montevideo, Uruguay: 2006. Estimación cuantitativa de la enfermedad de Chagas en las Américas.
-
- Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis. 2001;1:92–100. - PubMed
-
- Rassi A., Jr, Rassi S.G., Rassi A. Sudden death in Chagas' disease. Arq Bras Cardiol. 2001;76:75–96. - PubMed
-
- de Oliveira R.B., Troncon L.E., Dantas R.O., Menghelli U.G. Gastrointestinal manifestations of Chagas' disease. Am J Gastroenterol. 1998;93:884–889. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical